ACAMPROSATEACAMPROSATE

EUE-1

ACAMPROSATEACAMPROSATE

Outcome Predicators for Rate of Cumulative Abstinence Duration from Individual Patient Data across 16 European and U.S. Double-Blind Placebo-Controlled Trials (N=4457)

Outcome Predicators for Rate of Cumulative Abstinence Duration from Individual Patient Data across 16 European and U.S. Double-Blind Placebo-Controlled Trials (N=4457)

A universal model of predictors of outcome was shown to fit all studies

– abstinence at the onset of treatment

– medication compliance, both initial and continued

– moderate baseline alcohol dependence severity

– living with a partner and child

There was no significant interaction between treatment and whether the study was US or European

A universal model of predictors of outcome was shown to fit all studies

– abstinence at the onset of treatment

– medication compliance, both initial and continued

– moderate baseline alcohol dependence severity

– living with a partner and child

There was no significant interaction between treatment and whether the study was US or European